These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 1672176)

  • 1. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects.
    Taylor IK; O'Shaughnessy KM; Fuller RW; Dollery CT
    Lancet; 1991 Mar; 337(8743):690-4. PubMed ID: 1672176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction.
    O'Shaughnessy KM; Taylor IK; O'Connor B; O'Connell F; Thomson H; Dollery CT
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1431-5. PubMed ID: 8389105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics.
    Dahlén B; Zetterström O; Björck T; Dahlén SE
    Eur Respir J; 1994 Feb; 7(2):324-31. PubMed ID: 8162986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma.
    Twentyman OP; Finnerty JP; Holgate ST
    Am Rev Respir Dis; 1991 Oct; 144(4):782-7. PubMed ID: 1928949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
    Hamilton AL; Watson RM; Wyile G; O'Byrne PM
    Thorax; 1997 Apr; 52(4):348-54. PubMed ID: 9196518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma.
    Makker HK; Lau LC; Thomson HW; Binks SM; Holgate ST
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1413-8. PubMed ID: 8389103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
    Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
    J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma.
    Findlay SR; Barden JM; Easley CB; Glass M
    J Allergy Clin Immunol; 1992 May; 89(5):1040-5. PubMed ID: 1583246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled ICI 204,219 blocks antigen-induced bronchoconstriction in subjects with bronchial asthma.
    Nathan RA; Glass M; Minkwitz MC
    Chest; 1994 Feb; 105(2):483-8. PubMed ID: 8306751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.
    Smith LJ; Glass M; Minkwitz MC
    Clin Pharmacol Ther; 1993 Oct; 54(4):430-6. PubMed ID: 8222486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion.
    O'Shaughnessy KM; Wellings R; Gillies B; Fuller RW
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1472-6. PubMed ID: 8389108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist.
    Finnerty JP; Wood-Baker R; Thomson H; Holgate ST
    Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):746-9. PubMed ID: 1554195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of a late-phase response or increase in histamine responsiveness after bronchial provocation with adenosine 5'-monophosphate in atopic and non-atopic asthma.
    Phillips GD; Holgate ST
    Clin Sci (Lond); 1988 Oct; 75(4):429-36. PubMed ID: 2461826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.
    Smith LJ; Geller S; Ebright L; Glass M; Thyrum PT
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):988-92. PubMed ID: 2158260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist.
    Hui KP; Barnes NC
    Lancet; 1991 May; 337(8749):1062-3. PubMed ID: 1673495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005.
    Dahlén B; Kumlin M; Ihre E; Zetterström O; Dahlén SE
    Thorax; 1997 Apr; 52(4):342-7. PubMed ID: 9196517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5'-monophosphate and histamine in asthma.
    Polosa R; Phillips GD; Rajakulasingam K; Holgate ST
    J Allergy Clin Immunol; 1991 May; 87(5):939-47. PubMed ID: 1673977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects.
    Hamilton A; Faiferman I; Stober P; Watson RM; O'Byrne PM
    J Allergy Clin Immunol; 1998 Aug; 102(2):177-83. PubMed ID: 9723658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effect of terfenadine and flurbiprofen on early and late-phase bronchoconstriction following allergen challenge in atopic asthma.
    Hamid M; Rafferty P; Holgate ST
    Clin Exp Allergy; 1990 May; 20(3):261-7. PubMed ID: 1694714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study in atopic subjects with asthma of the effects of salmeterol and salbutamol on allergen-induced bronchoconstriction, increase in airway reactivity, and increase in urinary leukotriene E4 excretion.
    Taylor IK; O'Shaughnessy KM; Choudry NB; Adachi M; Palmer JB; Fuller RW
    J Allergy Clin Immunol; 1992 Feb; 89(2):575-83. PubMed ID: 1346794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.